化疗
医学
肿瘤科
放射治疗
打开标签
内科学
随机对照试验
作者
Ken Kato,Hiroyuki Daiko,Hiroyuki Daiko,Hiroyuki Daiko,Hiroyuki Daiko,Yuichi Shibuya,Hiroyuki Daiko,Yuichi Shibuya,Hiroyuki Daiko,Yuichi Shibuya,Hiroyuki Daiko,Hiroyuki Daiko,Yuichi Shibuya,Hiroyuki Daiko,Naoki Takegawa,Hiroyuki Daiko,Hiroyuki Daiko,Hiroyuki Daiko,Hiroyuki Daiko,Hiroyuki Daiko,Hiroyuki Daiko
出处
期刊:The Lancet
[Elsevier]
日期:2024-06-12
卷期号:404 (10447): 55-66
被引量:7
标识
DOI:10.1016/s0140-6736(24)00745-1
摘要
Neoadjuvant therapy is the standard treatment for patients with locally advanced oesophageal squamous cell carcinoma (OSCC). However, the prognosis remains poor and more intensive neoadjuvant treatment might be needed to improve patient outcomes. We therefore aimed to compare the efficacy and safety of neoadjuvant doublet chemotherapy, triplet chemotherapy, and doublet chemotherapy plus radiotherapy in patients with previously untreated locally advanced OSCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI